Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

153.23 +0.85 (+0.56%)
Streaming Delayed Price Updated: 12:22 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
53 54 Next >
Why Should You Invest in Blue Chip Stocks?
Here's why it's worth owning these Warren Buffett-style stocks. 
Via The Motley Fool
2 Ultra-Reliable Dividend Stocks You Can Buy Now and Hold Forever
Here are two stocks that investors can count on to deliver increasing dividend payments for many years to come. 
Via The Motley Fool
2 Cheap Tech Stocks to Buy Right Now
The stock market is down dramatically in 2022. That's great news for buyers, who can pick up fantastic stocks at bargain-bin prices these days. 
Via The Motley Fool
2 Bear Market Stocks That Can Make You Richer in 2022 and Beyond
A bear market can present fresh opportunities for long-term investors. 
Via The Motley Fool
Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims
 
Via Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
The three companies are changing the pharmaceutical industry. 
Via The Motley Fool
This Monster Dividend Stock Isn't Done Growing
Is another deal on the way for Johnson & Johnson? 
Via The Motley Fool
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
-Clinical Data Due Next Week at ASH- 
Via Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
These companies have long runways of growth ahead 
Via The Motley Fool
US Supports Delay On COVID Patent Waiver Extension Decision
Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could discourage pharma companies from responding rapidly to future global health... 
Via Benzinga
7 Iron-Clad Stocks That Will Resist the Market Turmoil
For investors that are concerned about the red ink but still want to stay in the market, these are the stocks to buy for volatility. 
Via InvestorPlace
Johnson & Johnson Unusual Options Activity
Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Why Is Yumanity Therapeutics (YMTX) Stock Up Today?
Yumanity Therapeutics (YMTX) stock is rocketing higher on Monday after the biopharmaceutical company announced a special dividend. 
Via InvestorPlace
If You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today
The stock for this healthcare stalwart beat the S&P 500's performance over the past decade. 
Via The Motley Fool
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
There are now two companies in the ring for a Horizon takeover. 
Via Investor's Business Daily
FTX Collapse: Lessons for Investors
Plus a look at "the dumbest index." 
Via The Motley Fool
Is Veeva Systems Stock a Buy Now?
The cloud-based customer relationship management company faces a lot of near-term headwinds. 
Via The Motley Fool
Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review
The S&P 500 is fighting for its 200-day, a critical level for the uptrend. 
Via Investor's Business Daily
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash
 
Via Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
This space is ripe with opportunities for investors. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why the Nasdaq Will Beat the Dow in 2023
This year's trends will eventually reverse. 
Via The Motley Fool
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
 
Via Benzinga
Why Horizon Therapeutics Stock Is Skyrocketing Today
Three big drugmakers could be interested in acquiring Horizon. 
Via The Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
Horizon Therapeutics (HZNP) stock is rising higher on Wednesday following reports that the company is considering a buyout. 
Via InvestorPlace
3 Top Dividend Kings to Buy for the Long Haul
Dividend stocks are an easy option to boost income. 
Via The Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist Before 2023
These stocks could grow Buffett's wealth -- and yours. 
Via The Motley Fool
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
The three companies have until Jan. 10 to decide whether they want to buy Horizon. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Will the Nasdaq or S&P 500 Have a Better 2023?
Depending on what the economy does, the performance of these indexes could be wildly different. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
53 54 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.